Close

Cantor Fitzgerald Raises Price Target on Compugen (CGEN) to $12 After 'Landmark Discovery'

December 28, 2009 3:19 PM EST Send to a Friend
Cantor Fitzgerald reiterates a 'Buy' rating on Compugen Ltd. (Nasdaq: CGEN), raises price target to $12.

Cantor analyst says, "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login